Erleada (apalutamide)

pCPA File Number: 21081
Negotiation Status:
Concluded with an LOI
Indication(s):
non-metastatic castrate resistant prostate cancer
Sponsor/Manufacturer:
Janssen Inc.
CADTH Project Number:
pCODR 10133
pCPA Engagement Letter Issued:
Negotiation Process Concluded: